Hsiao, WL Wendy

Nie, Shufang

Pan, Weisan

Yang, Zhijun

International Journal of Nanomedicine

English

PubMed

Zhijun Yang

Shufang Nie

WL Wendy Hsiao

Weisan Pam

Crossref

Thermoreversible Pluronic&reg; F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies

A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel.

A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. Diltiazem hydrochloride. Pharm Res.

A novel emulsificationsolvent extraction technique for production of protein loaded biodegradable microparticles for vaccine and drug delivery. J Control Release.

A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel.

A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA–paclitaxel microspheres.

A simple equation for the description of solute release. III. Coupling of diffusion and relaxation.

Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats.

Anti-tumor activity of paclitaxelloaded chitosan nanoparticles: an in vitro study. Mater Sci Eng C Biomim Mater Sens Syst.

Antitumor drug Paclitaxel-loaded pH-sensitive nanoparticles targeting tumor extracellular pH. Carbohydr Polym.

characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.

Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids. J Parenter Sci Technol.

Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic® F127 hydrogel for subcutaneous administration: in vitro and in vivo characterization.

Controlled release of vancomycin from poloxamer 407 gels.

Cremophor-free intravenous microemulsions for paclitaxel: II. Stability, in vitro release and pharmacokinetics.

Development and in vitro evaluation of sustained release poloxamer 407(P407) gel formulations of ceftiofur.

Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.

Development of nonionic surfactant/ phospholipid o/w emulsion as a paclitaxel delivery system. J Control Release.

Drug release mechanism of paclitaxel from a chitosan–lipid implant system: effect of swelling, degradation and morphology.

Effect of additives on the micellization of PEO/PPO/PEO block copolymer PF127 in aqueous solution. Colloids Surf A Physicochem Eng Asp.

Effect of hydroxypropyl β-cyclodextrin on the self-assembling and thermogelation properties of Poloxamer 407.

Effect of mammalian cell culture medium on the gelation properties of Pluronic F127.

Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers.

Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming units. Anticancer Drugs.

Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation.

Enhancement of carboplatin toxicity by Pluronic block copolymers.

Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule.

Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins.

Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.

Evaluation of poly(ethylene oxide)–poly(propylene oxide)–poly(ethylene oxide) (PEO–PPO–PEO) gels as a release vehicle for percutaneous fentanyl.

Folic acid–Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.

In vitro cytotoxicity of paclitaxel/β-cyclodextrin complexes for HIPEC.

In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.

In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of paclitaxel: gel, film, prodrug, liposomes and micelles. Current Drug Deliv.

Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation. Pharm Dev Techno.

Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides. Pharm Res.

Localized delivery to CT-26 tumors in mice using thermosensitive liposomes.

Long-term in vitro study of paclitaxel-eluting bioresorbable core/shell fiber structures.

Loss of gelation ability of Pluronic® F127 in the presence of some salts.

Mechanisms of solute release from porous hydrophilic polymers.

Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev.

Multidrug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.

On the theory of lower critical solution pointing hydrogen-bonded mixtures.

OncoGel (ReGel/paclitaxel) – clinical applications for a novel paclitaxel delivery system. Adv Drug Deliv Rev.

Oral microemulsions of paclitaxel: In situ and pharmacokinetic studies.

Paclitaxel in cancer therapy. Expert Opin Pharmacother.

Paclitaxel release from microporous PLGA disks. Chem Eng Sci.

Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant.

Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.

Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.

Paclitaxel/β-cyclodextrin complexes for hyperthermic peritoneal perfusion – formulation and stability.

Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention. Cancer Res.

Phase diagrams and aggregation behavior of poly(oxyethylene)–poly(oxypropylene)–poly(oxyethylene) triblock copolymes in aqueous solutions.

Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers.

Polyoxyethylenepolyoxypropylene block copolymer gels as sustained release vehicles for subcutaneous drug administration.

Preparation and characterization of water-soluble prodrug, liposomes and micelles of paclitaxel. Current Drug Deliv.

Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome.

Promotion of microtubule assembly in vitro by Taxol.

Salt effects on the diffusion and release rate of propranolol from poloxamer 407 gels.

Stable paclitaxel formulations in oily contrast medium.

Structure and assembly of PEO– PPO–PEO co-polymers in mammalian cell-culture media.

Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.

Study of the gelation process of polyethylene oxidea-polypropylene oxideb-polyethylene oxidea copolymer. J Colloid Interface Sci.

Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice. Pharm Res.

Swelling and drug release in hydrogel matrices: polymer viscosity and matrix porosity effects.

Synergistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo.

Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles.

Taxol sensitizes human astrocytoma cells to radiation. Cancer Res.

The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.

The effect of pharmaceuticals on the nanoscale structure of PEO–PPO–PEO micelles. Colloids Surf.

Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release.

Thermoreversible liposomal poloxamer gel for the delivery of paclitaxel: dose proportionality and hematological toxicity studies.

Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.

Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin–biotin technology: formulation development and in vitro anticancer activity.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3075891

Thermoreversible Pluronic® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies

Thermoreversible Pluronic® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies

Abstract

Similar works

Full text

Available Versions

Crossref